Authors: Wessel, I Jensen, LH Jensen, PB Falck, J Rose, A Roerth, M Nitiss, JL Sehested, M

Citation: I. Wessel et al., Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform, CANCER RES, 59(14), 1999, pp. 3442-3450